Simcere (02096) Releases January 2026 Monthly Return With No Change in Issued Shares
Bulletin Express
Feb 04
Simcere Pharmaceutical Group Limited (02096) published its monthly return for the period ended January 31, 2026, confirming that the total number of issued shares remained at 2,595,697,618 with no adjustment during the month.
The company reconfirmed compliance with a public float requirement of 15.45%. Details also indicate that 10,851,000 shares had been repurchased for cancellation but not yet cancelled as of January 31, 2026. Furthermore, no new issuances were recorded under the restricted share unit scheme, leaving 237,370,361 shares still available for issuance or transfer under the plan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.